Nationwide survey of experiential learning in MPharm programmes in UK Universities

The International Journal of Pharmacy Practice
Sabrina Anne Jacob, Anne C Boyter

Abstract

To determine the current structure of experiential learning (EL) in Master of Pharmacy (MPharm) programmes in UK universities, and assess how they meet the standards specified by the General Pharmaceutical Council. A cross-sectional survey of staff in charge of EL in MPharm programmes was conducted, utilising a 31-item online survey, consisting of both open-ended and close-ended questions. Variables of interest were administrative aspects and structure of the EL component, tutor issues and placement sites. To pinpoint the challenges faced with EL, the Relative Importance Index (RII) was calculated. Twenty (66.7%) universities responded. EL coordinators were mostly academic/teaching fellows (19) and spent 0.29 ± 0.31 full-time equivalents on coordination. Tutors completed training annually in 53.8% of universities, with topics focusing on placement structure (85.7%) and requirements (78.6%). Total placement hours in all practice sites over the 4 years of study ranged from 54 to 496 h, and included hospitals, community pharmacies, hospices, prisons and nursing homes. The three biggest challenges faced with regard to EL were in obtaining/retaining hospital placements (1st), financial support (2nd) and quality assurance (QA) of tut...Continue Reading

References

Apr 5, 2005·The Australian Journal of Rural Health·Jennifer MarriottMiranda Rose
May 20, 2006·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·C Richard Talley
Nov 13, 2008·American Journal of Pharmaceutical Education·William R Wuller, Mark S Luer
Mar 28, 2009·American Journal of Pharmaceutical Education·Michael Hal Sosabowski, Paul R Gard
Jun 11, 2009·American Journal of Pharmaceutical Education·Cynthia J BoyleMagaly Rodriguez de Bittner
Jul 7, 2009·Pharmacy World & Science : PWS·H Laetitia HattinghNerida A Smith
Apr 1, 2011·American Journal of Pharmaceutical Education·Mitra AssemiPeter J Ambrose
May 11, 2011·Journal of the American Pharmacists Association : JAPhA·Henri R Manasse, Thomas E Menighan
May 27, 2011·Australian Health Review : a Publication of the Australian Hospital Association·Lynda R MatthewsJill F White
Aug 11, 2011·American Journal of Pharmaceutical Education·Chanel F AgnessNicole Brandt
Oct 5, 2011·American Journal of Pharmaceutical Education·Charles H McDuffieElizabeth S McCullough
Aug 25, 2012·The Canadian Journal of Hospital Pharmacy·Kevin HallJames E Tisdale
Nov 30, 2012·American Journal of Pharmaceutical Education·Bridget Paravattil
Nov 26, 2013·Journal of Professional Nursing : Official Journal of the American Association of Colleges of Nursing·Marie Annette Brown, Katherine Crabtree
Mar 6, 2015·American Journal of Pharmaceutical Education·Jennifer DanielsonTeresa A O'Sullivan
May 23, 2015·American Journal of Pharmaceutical Education·Patricia S Devine, Patricia L Darbishire
Jan 17, 2017·American Journal of Pharmaceutical Education·Philip Winn, Christopher J Turner
Feb 10, 2017·American Journal of Pharmaceutical Education·Gillian HendryChristopher J Turner
Oct 1, 2017·The Spine Journal : Official Journal of the North American Spine Society·David J KennedyByron J Schneider
May 17, 2018·Currents in Pharmacy Teaching & Learning·Craig D CoxSheila Walter

❮ Previous
Next ❯

Citations

Apr 22, 2020·American Journal of Pharmaceutical Education·Catherine LangranParastou Donyai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.